Many payments to doctors made by pharmaceutical and medical device companies will not be included in the public release of the database next month. Federal officials cite data inconsistencies, say records will be posted next June.
The Consumer Financial Protection Bureau’s action addresses one small aspect of the company’s business practices which also includes thousands of lawsuits against service members who fall behind on their payments.
For years, Dr. Michael Reinstein prescribed the powerful drug clozapine more than any other doctor in Medicare or Medicaid. His patterns were the subject of two ProPublica articles and he faces a federal civil lawsuit alleging health care fraud.